Expired activity
Please go to the PowerPak homepage and select a course.

How Will New DOAC-Specific Reversal Agents Impact Patient Outcomes and Healthcare Delivery? (Recorded Podcast)

» References (PDF)

PRESENTER

Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS-AQ
Associate Professor
University of Colorado Skaggs School of Pharmacy
Aurora, CO

MEDICAL WRITER

Katherine Wandersee

LEARNING OBJECTIVES

Upon completion of this program, participants should be better able to:

  • Describe DOAC-specific reversal agents available or under development and analyze their place in practice
  • Discuss the impact and future effect of DOAC reversal agents on patient care and healthcare delivery

Back to Top